- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
CMS Proposes Change to Evaluation-and-Management Payment Model
Many physicians who treat Medicare patients may see an end to unreimbursed evaluation-and-management (E&M)
Many physicians who treat Medicare patients may see an end to unreimbursed evaluation-and-management (E&M). Starting in 2015, the Centers for Medicaid & Medicare Services (CMS) is proposing reimbursement for patient care-management activities that don't involve face-to-face contant. Modern Healthcare reports:
Medicare beneficiaries with chronic conditions generate a set fee for each visit to the Center for Primary Care in Augusta, Ga. Yet that visit will generate numerous tasks—including making referrals to calling in prescriptions to answering questions over the telephone from the patient's spouse. None is reimbursed by the CMS.
“For every E&M visit we get reimbursed for, there are seven other items of work that we don't get reimbursed for,” said Dr Paul Fischer, founder of the Center for Primary Care. “The vast majority of our work gets done outside of the 15 minutes you spend in the exam room.”
For hundreds of thousands of primary-care physicians across the country like the 27 who practice at the seven sites run by the Center for Primary Care, the era of unreimbursed evaluation-and-management, or E&M, care may finally be coming to an end. Recognizing that care coordination may hold the key to keeping healthcare costs in check for an aging population, the CMS last week proposed reimbursing doctors starting in 2015 for patient care-management activities that don't involve face-to-face contact.
Read the full story here: http://bit.ly/12AClZo
What We’re Reading: RSV Vaccine Demand; Permanent Contraception; Drug Negotiation Impact
December 8th 2023The Biden administration recently met with manufacturers of respiratory syncytial virus (RSV) immunizations to encourage them to increase access to the vaccine; since the Dobbs v Jackson decision, many patients have been seeking more permanent reproductive health care solutions; a Mathematica analysis showed that Medicare prescription drug price negotiations could have cut seniors’ out-of-pocket costs by nearly a quarter had the program been in effect in 2021.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Data analysis showed that 40% of patients who filled a prescription for Wegovy in 2021 or 2022 were still taking it a year later; both Democrats and reproductive rights organizations are pressuring the Biden administration to ensure health insurers fully cover contraception; CMS implemented Medicare changes in March that limited access to blood tests that help transplant recipients ensure their organs remain healthy.
Read More
Oncology Onward: A Conversation With Dr Debra Patt of Texas Oncology
August 1st 2023Debra Patt, MD, PhD, MBA, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for episode 2 of our newest podcast, "Oncology Onward: Conversations With Innovators and Changemakers in Cancer Care."
Listen
